ICD-10-CM 2027 diagnosis code
H36.89Other retinal disorders in diseases classified elsewhere
H36.89 is a valid, billable ICD-10-CM code for other retinal disorders in diseases classified elsewhere. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.
Code last changed in FY2024 (effective October 1, 2023). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About H36.89
H36.89 is the ICD-10-CM diagnosis code for other retinal disorders in diseases classified elsewhere. It belongs to category H36 (retinal disorders in diseases classified elsewhere), block H30-H36 (disorders of choroid and retina) and chapter 7 (diseases of the eye and adnexa). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within H36.8, choose H36.89 (Other retinal disorders in diseases classified elsewhere) only when documentation doesn't support a more specific option: nonproliferative sickle-cell retinopathy (H36.81) and proliferative sickle-cell retinopathy (H36.82).
Code first underlying disease, such as: lipid storage disorders (E75.-) and sickle-cell disorders (D57.-).
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It is a manifestation code, so it describes the effect of an underlying disease and can't be the principal diagnosis. Code the underlying condition first.
It was added in FY2024, effective October 1, 2023.
Coding notes
- Retinal dystrophy in lipid storage disorders
Notes that apply from higher levels
Instructions written at a parent level also apply to H36.89.
Broader instructions also apply from Chapter 7: Diseases of the eye and adnexa.
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 02 · Diseases and Disorders of the Eye
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2024 (effective 10/1/2023): Added
- No changes since FY2024.
Common questions about H36.89
Is H36.89 billable?
- Yes. H36.89 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can H36.89 be used as a principal diagnosis?
- No. It is a manifestation code, so it describes the effect of an underlying disease and can't be the principal diagnosis. Code the underlying condition first.
Is H36.89 a CC or MCC?
- No. H36.89 is neither a CC nor an MCC under MS-DRG v44.0.
What DRG does H36.89 group to?
- H36.89 is used in the MS-DRG v44.0 logic for MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.